Ken Perry
- Neurology top 2%
-
- Neuroscience and Neuropharmacology Research 6
- Neurotransmitter Receptor Influence on Behavior 6
- Genetic Neurodegenerative Diseases 2
- Biological Psychiatry top 10%
- Neurology top 5%
- Developmental Neuroscience top 10%
-
- Attention Deficit Hyperactivity Disorder 5
-
- Receptor Mechanisms and Signaling 2
-
- Hormonal and reproductive studies 1
-
- Amino Acid Enzymes and Metabolism 1
-
- HIV Research and Treatment 1
- Co-authors
- Ray W. FullerLee A. PhebusFrank P. BymasterRichard DodelYansheng DuZhizhong MaDavid L. NelsonEyassu Chernet
- Journals
- Journal of Pharmacology and Experimental Therapeutics (4 papers)Developmental Brain Research (2 papers)Acta Neurobiologiae Experimentalis (1 paper)
- Partner nations
- United StatesPolandSingapore
In The Last Decade
Ken Perry
17 papers receiving 958 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Neurology 351
- Cellular and Molecular Neuroscience 485
- Biological Psychiatry 52
- Neurology 299
- Developmental Neuroscience 52
Countries citing papers authored by Ken Perry
This map shows the geographic impact of Ken Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Perry more than expected).
Fields of papers citing papers by Ken Perry
This network shows the impact of papers produced by Ken Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Perry. The network helps show where Ken Perry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ken Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2021 | 5 | |
| 3 | 2013 | 29 | |
| 4 | 2003 | 25 | |
| 5 | 2003 | 11 | |
| 6 | 2002 | 1 | |
| 7 | Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseasebreakdown → | 2001 | 655 |
| 8 | Habitat monitoring for conservation management and reporting | 2001 | 2 |
| 9 | 1998 | 2 | |
| 10 | 1997 | 22 | |
| 11 | 1996 | 1 | |
| 12 | 1994 | 51 | |
| 13 | 1994 | 58 | |
| 14 | 1993 | 34 | |
| 15 | 1993 | 38 | |
| 16 | 1993 | 10 | |
| 17 | 1975 | 25 |
About Ken Perry
Ken Perry is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Virology, Computer Science Applications and Pharmaceutical Science, having authored 17 papers that have together received 974 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Attention Deficit Hyperactivity Disorder (5 papers), Receptor Mechanisms and Signaling (2 papers), Genetic Neurodegenerative Diseases (2 papers), Hormonal and reproductive studies (1 paper), Amino Acid Enzymes and Metabolism (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Neurology (351 citations), Cellular and Molecular Neuroscience (485 citations), Biological Psychiatry (52 citations), Neurology (299 citations) and Developmental Neuroscience (52 citations). Ken Perry has collaborated with scholars based in United States, Poland and Singapore. Frequent co-authors include Ray W. Fuller, Lee A. Phebus, Frank P. Bymaster, Richard Dodel, Yansheng Du, Zhizhong Ma, David L. Nelson, Eyassu Chernet, Feng Gao and Suizhen Lin. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Developmental Brain Research, Acta Neurobiologiae Experimentalis, Neurotoxicity Research and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.